Search results for " Emission"

showing 10 items of 1496 documents

Energy potential and CO2 budget of residual biomass in the Menfi wine district, Sicily

2008

CO2 emissions renewable energy ligno -cellusic residuesSettore AGR/02 - Agronomia E Coltivazioni Erbacee
researchProduct

Quantifying carbon dioxide flux from dormant volcanoes with low-temperature fumarolic activity: demonstration from measurements at La Soufrière, Guad…

2013

Quantifying the flux of magma derived CO2 dissipated by fumarolic fields at dormant volcanoes is fundamental to assess their current state of hydrothermal activity and, therefore, the likelihood of a future phreatic/magmatic eruption. There is, in fact, documented evidence that gas fluxes, and CO2 flux in particular, can increase substantially during volcanic unrests and prior to eruption, due to either degassing of new ascending magma or changes in the hydrothermal system physical regime. Quantifying CO2 emissions is relatively straightforward at open-conduit volcanoes with high-temperature gas venting, which release high enough quantities of SO2 remotely measurable with UV spectroscopy an…

CO2 emissions soufriere guadeloupe campi flegrei
researchProduct

Pollutant Emissions in Ports: A Comprehensive Review

2021

In recent decades, maritime transport demand has increased along with world population and global trades. This is associated with higher pollution levels, including the emissions of GHG and other polluting gases. Ports are important elements within maritime transport and contribute themselves to pollutant emissions. This paper aims to offer a comprehensive yet technical review of the latest related technologies, explaining and covering aspects that link ports with emissions, i.e., analyzing, monitoring, assessing, and mitigating emissions in ports. This has been achieved through a robust scientific analysis of very recent and significant research studies, to offer an up-to-date and reliable…

CO<sub>2</sub>PortsPollutionTechnologyPollutant emissionsmedia_common.quotation_subjectComputerApplications_COMPUTERSINOTHERSYSTEMSGeneral Materials ScienceCivil and Structural Engineeringmedia_commonbusiness.industryTRenewable energiesBuilding and ConstructionWorld populationEnvironmental economicsGeotechnical Engineering and Engineering GeologyPort (computer networking)Computer Science ApplicationsRenewable energyMaritime transportEmissionsGreenhouse gasSustainabilityResearch studiesCO2businessInfrastructures
researchProduct

The one loop gluon emission light cone wave function

2017

Light cone perturbation theory has become an essential tool to calculate cross sections for various small-$x$ dilute-dense processes such as deep inelastic scattering and forward proton-proton and proton-nucleus collisions. Here we set out to do one loop calculations in an explicit helicity basis in the four dimensional helicity scheme. As a first process we calculate light cone wave function for one gluon emission to one-loop order in Hamiltonian perturbation theory on the light front. We regulate ultraviolet divergences with transverse dimensional regularization and soft divergences with using a cut-off on longitudinal momentum. We show that when all the renormalization constants are comb…

COLLISIONSParticle physicsNuclear TheoryRENORMALIZATIONQUANTUM ELECTRODYNAMICSGeneral Physics and AstronomyFOS: Physical sciencesloop calculations114 Physical sciences01 natural scienceslight cone perturbation theoryRenormalizationNuclear Theory (nucl-th)Dimensional regularizationHigh Energy Physics - Phenomenology (hep-ph)INFINITE-MOMENTUMLight cone0103 physical sciencesSCATTERINGHelicity basis010306 general physicsNuclear ExperimentQuantum chromodynamicsPhysicsCoupling constantgluon emissionta114010308 nuclear & particles physicsCOLOR GLASS CONDENSATEDeep inelastic scatteringFRONT QCDHelicityEVOLUTIONHigh Energy Physics - PhenomenologyCHROMODYNAMICSQuantum electrodynamicsgluon saturation
researchProduct

Clinical evaluation of [68Ga]Ga-DATA-TOC in comparison to [68Ga]Ga-DOTA-TOC in patients with neuroendocrine tumours

2019

Abstract Introduction [68Ga]Ga-DATA-TOC is a new radiolabelled somatostatin-analogue for positron emission tomography (PET) imaging of neuroendocrine tumours. Its advantage over DOTA-conjugated compounds is the possibility for high-efficiency labelling with gallium-68 quickly at room temperature with high reliability and without the need for product purification, which enables the development of an instant kit-type labelling method. We evaluated its imaging characteristics in patients with neuroendocrine tumours in comparison to [68Ga]Ga-DOTA-TOC. Methods 19 patients imaged with [68Ga]Ga-DATA-TOC were retrospectively analysed and uptake in normal tissues was compared with a group of 19 pati…

Cancer ResearchPET-CTBiodistributionmedicine.diagnostic_testSomatostatin receptorbusiness.industry030218 nuclear medicine & medical imagingLesion03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSomatostatinchemistryPositron emission tomography030220 oncology & carcinogenesismedicineMolecular MedicineDOTARadiology Nuclear Medicine and imagingIn patientmedicine.symptombusinessNuclear medicineNuclear Medicine and Biology
researchProduct

Metabolic Imaging in Microregions of Tumors and Normal Tissues With Bioluminescence and Photon Counting

1988

A method has been developed for metabolic imaging on a microscopic level in tumors, tumor spheroids, and normal tissues. The technique makes it possible to determine the spatial distribution of glucose, lactate, and ATP in absolute terms at similar locations within tissues or cell aggregates. The substrate distributions are registered in serial cryostat sections from tissue cryobiopsies or from frozen spheroids with the use of bioluminescence reactions. The light emission is measured directly by a special imaging photon counting system enabling on-line image analysis. The technique has been applied to human breast cancer xenografts, to spheroids originating from a human colon adenocarcinoma…

Cancer ResearchPathologymedicine.medical_specialtyCellBiologyAdenosine TriphosphateNeoplasmsmedicineMedical imagingAnimalsHumansBioluminescenceLarge intestineLactic AcidRadionuclide ImagingRadiationMusclesSpheroidMammary Neoplasms Experimentalmedicine.diseasePhoton countingRatsGlucosemedicine.anatomical_structureOncologyColonic NeoplasmsLuminescent MeasurementsLactatesBiophysicsAdenocarcinomaFemaleLight emissionJNCI Journal of the National Cancer Institute
researchProduct

Establishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool

2020

Purpose The utility of 18-fluordesoxyglucose positron emission tomography ([18F]-FDG-PET) combined with computer tomography or magnetic resonance imaging (MRI) in gastric cancer remains controversial and a rationale for patient selection is desired. This study aims to establish a preclinical patient-derived xenograft (PDX) based [18F]-FDG-PET/MRI protocol for gastric cancer and compare different PDX models regarding tumor growth and FDG uptake. Materials and methods Female BALB/c nu/nu mice were implanted orthotopically and subcutaneously with gastric cancer PDX. [18F]-FDG-PET/MRI scanning protocol evaluation included different tumor sizes, FDG doses, scanning intervals, and organ-specific …

Cancer ResearchPathologymedicine.medical_specialtyStandardized uptake value03 medical and health sciences0302 clinical medicinemedicineAviditymedicine.diagnostic_testbiologybusiness.industryXenograftGastroenterologyGlucose transporterCancerMagnetic resonance imagingPET scanmedicine.diseasecarbohydrates (lipids)OncologyPositron emission tomography030220 oncology & carcinogenesisbiology.proteinImmunohistochemistry030211 gastroenterology & hepatologyGLUT1Original ArticlebusinessGastric cancerGlycolysisJournal of Gastric Cancer
researchProduct

Phase 0/1 of Positron Emission Tomography (PET) imaging agent [18F]-ODS2004436 as a marker of EGFR mutation in patients with non-small cell lung canc…

2018

e24184Background: Multiple EGFR tyrosine kinase inhibitors (TKIs) are approved for treatment of NSCLC harboring EGFR activating mutations or secondary TKIs resistant mutation. We evaluate a new PET...

Cancer Research[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imagingnon-small cell lung cancer (NSCLC)[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine03 medical and health sciences0302 clinical medicinemedicineIn patientComputingMilieux_MISCELLANEOUSmedicine.diagnostic_testbusiness.industryPet imagingmedicine.diseaseEGFR Tyrosine Kinase Inhibitorsrespiratory tract diseases3. Good health[SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/ImagingOncologyEgfr mutationPositron emission tomography030220 oncology & carcinogenesisMutation (genetic algorithm)Cancer researchbusiness030215 immunology
researchProduct

Improved inter-observer agreement of an expert review panel in an oncology treatment trial--Insights from a structured interventional process.

2015

Abstract Purpose Oncologic imaging is a key for successful cancer treatment. While the quality assurance (QA) of image acquisition protocols has already been focussed, QA of reading and reporting offers still room for improvement. The latter was addressed in the context of a prospective multicentre trial on fluoro-deoxyglucose (FDG)–positron-emission tomography (PET)/CT-based chemoradiotherapy for locally advanced non-small cell lung cancer (NSCLC). Material and methods An expert panel was prospectively installed performing blinded reviews of mediastinal NSCLC involvement in FDG–PET/CT. Due to a high initial reporting inter-observer disagreement, the independent data monitoring committee (I…

Cancer Researchmedicine.medical_specialtyLung NeoplasmsContext (language use)Sensitivity and SpecificityDouble-Blind MethodFluorodeoxyglucose F18Carcinoma Non-Small-Cell LungOutcome Assessment Health CaremedicineData monitoring committeeHumansMedical physicsObserver VariationPET-CTmedicine.diagnostic_testbusiness.industryReproducibility of ResultsChemoradiotherapyClinical trialOncologyPositron emission tomographyPositron-Emission TomographyRadiologybusinessTomography X-Ray ComputedQuality assuranceKappaChemoradiotherapyEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Blood flow and metabolic microenvironment of brain tumors

1994

Summarizing thesein vivo data in the context of brain tumor therapy, the following aspects are of particular importance: Low and heterogeneous tumor blood flow may — in addition to the limiting effects of the blood-brain barrier — result in compromised delivery of drugs from blood to the tissue. Low tumor pO2 reduces sensitivity to standard radiation and ‘O2-dependent’ anticancer drugs. Treatment efficacy may be further altered by changes of tumor pH. Particularly acidosis can decrease radiation sensitivity and modulate the cytotoxicity of anticancer drugs. In the following presentations, these aspects will be discussed regardingin vivo data obtained with positron emission tomography.

Cancer Researchmedicine.medical_specialtyNeurologyPartial PressureBrain tumorContext (language use)AstrocytomaPharmacologyOxygen ConsumptionRadiation sensitivitymedicineAnimalsHumansCytotoxicityAcidosismedicine.diagnostic_testBrain Neoplasmsbusiness.industryGliomaBlood flowmedicine.diseaseOxygenNeurologyOncologyRegional Blood FlowPositron emission tomographyCerebrovascular CirculationNeurology (clinical)medicine.symptombusinessJournal of Neuro-Oncology
researchProduct